Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:12 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2089–2112 of 3,253 matching trials from the live ClinicalTrials.gov search.

Filters: Not yet recruiting Clear all

Conditions: Liver Fibrosis Due to NASH, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Alcohol Liver Disease
Interventions: Not listed
Lead sponsor: Fibronostics USA, Inc; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Timeline: 2025
U.S. locations: 1
States / cities: Lady Lake, Florida

Conditions: Traumatic Injury, Posttraumatic Stress Disorder, Depression, Social Determinants of Health
Interventions: CHW support; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Venezuelan Equine Encephalomyelitis
Interventions: 0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1; Biological
Lead sponsor: U.S. Army Medical Research and Development Command; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Fort Deterick, Maryland

Conditions: Cancer Survivors
Interventions: Transdiagnostic Sleep Health Intervention (TSHI); Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Mobility Disability
Interventions: We Innovate Mobility (WIM) Device, Conventional Treadmill Walking; Device · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 65 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Severe Preeclampsia, Eclampsia Preeclampsia
Interventions: Levetiracetam, magnesium sulfate; Drug
Lead sponsor: Nebraska Methodist Health System; Other
Eligibility: 19 Years and older · Female only
Enrollment: 1,240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2034
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Emotional Dysregulation
Interventions: N-Acetyl Cysteine (NAC), Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 12 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 2
States / cities: Boston, Massachusetts • Cambridge, Massachusetts

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Verducatib, Placebo matching verducatib; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years and older
Enrollment: 1,800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 18
States / cities: Birmingham, Alabama • Phoenix, Arizona • La Palma, California + 14 more

Conditions: Melanoma, Li-Fraumeni Syndrome, Pulmonary Blastoma, Chordoma, Congenital Bone Marrow Failure Syndromes, Costello Syndrome, Fanconi Anemia, CFC Syndrome (CFCS), Legius Syndrome, RASopathies
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 1 Year to 99 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2036
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Opioid Use Disorder
Interventions: KIOS App; Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: HIV Infections
Interventions: Health MPowerment App; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 14 Years to 21 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Fertility, Male Fertility, Sperm Count, Low, Sperm Quality
Interventions: EDC Education Intervention; Behavioral
Lead sponsor: Million Marker Wellness, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Sensorineural Hearing Loss, Bilateral Hearing Loss, Cochlear Implantation, Hearing Disorders, Hearing Disorders and Deafness, Inner Ear Disorders, Hearing Impairment
Interventions: IotaSoft Robotic Insertion System, Manual Cochlear Implant Insertion; Device · Procedure
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years to 80 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Kissimmee, Florida

Conditions: Dup15Q Syndrome
Interventions: Basmisanil, Placebo; Drug
Lead sponsor: Newleos Therapeutics, Inc.; Industry
Eligibility: 2 Years to 14 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Endometrial Cancer
Interventions: Signatera Genome ultra-sensitive ctDNA blood test; Device
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 1,010 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2034
U.S. locations: 12
States / cities: Birmingham, Alabama • La Jolla, California • Los Angeles, California + 9 more

Conditions: Traumatic Brain Injury, Traumatic Brain Injury (TBI), Hemiplegia and Hemiparesis
Interventions: Transcutaneous Spinal Cord Stimulation, Sham; Procedure · Other
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Chicago, Illinois • West Orange, New Jersey

Conditions: Cancer
Interventions: Dyadic Life Review; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 50 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Accidental Overdose of Opiate
Interventions: Overdose prevention resources, Overdose prevention education; Other · Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Kidney Transplant, Urinary Tract Infection(UTI), Antibiotic Prophylaxis, Remote Patient Monitoring, Feasibility Pilot Study
Interventions: Trimethoprim-Sulfamethoxazole (TMP-SMX), Usual Care; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 12 Years to 29 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028 – 2033
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Discogenic Low Back Pain
Interventions: Platelet-Rich Plasma (PRP) Injection, Nucleus Pulposus (NP) Injection; Biological
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years to 100 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Colorectal Cancer (CRC) Screening, CRC Screening, Rectal Cancer, Colon Cancer, Colorectal Cancer
Interventions: Colorectal Cancer Education Materials, Cologuard test kit, Fecal immunochemical test kit, Usual Care; Behavioral · Diagnostic Test
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 45 Years to 75 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Chronic Stroke Survivors, Chronic Stroke Patients, Stroke
Interventions: Robot-assisted gait training and transcutaneous spinal cord stimulation in chronic non-ambulatory stroke survivors: pilot RCT trial, Robot assisted gait training alone; Device
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Childhood Obesity, Evidence-Based Practice, Food Systems, Food Policy
Interventions: Catalyzing Communities, FICAS Implementation Intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 3,300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Insomnia, Malignant Solid Neoplasm
Interventions: Biospecimen Collection, Placebo Administration, Single Agent Therapy; Procedure · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 25 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

CHW-Enhanced Trauma Recovery

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults

Improving Sleep, Fatigue, Activity & Quality of Life in Cancer Survivors Via a Transdiagnostic Intervention

Wearable Robotics to Overcome Exercise Dose Limitations in Older Adults - Study 2

Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure

The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation

The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease

Clinical Genetics Branch Eligibility Screening Survey

Real World Evaluation of the Effectiveness and Implementation of a Digital Health Therapeutic for OUD

Integrating Supports to Promote PrEP for Black Adolescents Working With Apps- Atlanta

Sperm, Exposure and Endocrine Disruptors

Comparative Analysis of Hearing Outcomes: Robotic vs. Manual Insertion of Cochlear Implants

A Phase II Study of Basmisanil in Children and Adolescents With Dup15q Syndrome

Signatera Assessment in Early-Stage Endometrial Cancer

Spinal Stimulation and Gait Training to Improve Mobility in TBI

Dyadic Life Review Intervention for Older Patients With Advanced Cancer and Alzheimer's Disease and Related Dementias and Their Caregivers

Remote Intervention to Prevent Overdose

Antibiotics for Kidney Transplant Recipients

PRP Versus NP Injections for Chronic Discogenic Low Back Pain

Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach

Walking and tSCS in Non-ambulatory Stroke Survivors

Network-Based Support to Help Community Coalition Members Choose and Use Strategies to Improve Child Health

THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia